Loading...

APC anti-mouse IL-4 Antibody

Pricing & Availability
Clone
11B11 (See other available formats)
Regulatory Status
RUO
Other Names
Interleukin-4, Ia inducing factor (IaIF), B cell stimulating factor-1 (BSF-1), Hodgkin's cell growth factor (HCGF), Mast cell growth factor-2 (MCGF-2), Macrophage fusion factor (MFF), T cell growth factor-2 (TCGF-2)
Isotype
Rat IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
11B11_APC_1_051311
PMA+ionomycin-stimulated (6 hours, in presence of brefeldin A) Th2-polarized C57BL/6 CD4-positive cells were surface stained with CD3 PE and then intracellularly stained with IL-4 (11B11) APC (top) or rat IgG1, κ APC isotype control (bottom).
  • 11B11_APC_1_051311
    PMA+ionomycin-stimulated (6 hours, in presence of brefeldin A) Th2-polarized C57BL/6 CD4-positive cells were surface stained with CD3 PE and then intracellularly stained with IL-4 (11B11) APC (top) or rat IgG1, κ APC isotype control (bottom).
  • 11B11_APC_2_051311
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
504105 25 µg 88 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
504106 100 µg 275 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

IL-4 is a pleiotropic cytokine produced by activated T cells, mast cells, and basophils. IL-4 is a potent lymphoid cell growth factor which stimulates the growth and activation of certain B cells and T cells. IL-4 is important for regulation of T helper subset development.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Partially purified native mouse IL-4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

ELISA1,2,10,13 or ELISPOT5 Capture: The purified 11B11 antibody is useful as the capture antibody in a sandwich ELISA or ELISPOT assay, when used in conjunction with the biotinylated BVD6-24G2 antibody (Cat. No. 504202) as the detecting antibody and recombinant mouse IL-4 (Cat. No. 575609) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture.
Neutralization1-2,9,12: The 11B11 antibody can neutralize the bioactivity of natural or recombinant IL-4. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IL-4 bioactivity in vivo and in vitro (Cat. No. 504108).
Additional reported applications (for the relevant formats) include: immunoprecipitation16, immunohistochemical staining of formalin-fixed paraffin-embedded tissue sections8 and paraformaldehyde-fixed, saponin-treated frozen tissue sections6,7, and immunocytochemistry4.
Note: For testing mouse IL-4 in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 431101 to 431106) are specially developed and recommended.

Application References

(PubMed link indicates BioLegend citation)
  1. Shirai A, et al. 1994. Cytokine 6:329. (ELISA, Neut)
  2. Abrams J. 1995. Curr. Prot. Immunol. John Wiley and Sons New York. Unit 6.20. (ELISA, Neut)
  3. Assenmacher M, et al. 1994. Eur. J. Immunol. 24:1097.
  4. Openshaw P, et al. 1995. J. Exp. Med. 182:1357. (ICC)
  5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons New York. Unit 6.19. (ELISA Capture)
  6. Litton M, et al. 1994. J. Immunol. Methods 175:47. (IHC)
  7. Andersson U, et al. 1999. Detection and quantification of gene expression. New York:Springer-Verlag. (IHC)
  8. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  9. Hara M, et al. 2001. J. Immunol. 166:3789. (Neut)
  10. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
  11. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  12. Wang W, et al. 2007. J. Immunol. 178:4885. (Neut)
  13. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
  14. Ohnmacht C, et al. 2008. Blood 113:2816. PubMed
  15. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  16. Zavorotinskaya T, et al. 2003. Mol. Ther. 7:155. (IP)
Product Citations
  1. McCauley KE, et al. 2022. Cell Rep Med. 3:100713. PubMed
  2. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  3. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  4. Sun Y, et al. 2023. Cell Mol Life Sci. 80:63. PubMed
  5. Nanishi E, et al. 2023. NPJ Vaccines. 8:18. PubMed
  6. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  7. Elong Ngono A, et al. 2020. Cell Reports. 1.330555556. PubMed
  8. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  9. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  10. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  11. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  12. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  13. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  14. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  15. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  16. Pu Y, et al. 2022. Transl Psychiatry. 12:223. PubMed
  17. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  18. Chang Q, et al. 2020. Scand J Immunol. 92:e12877. PubMed
  19. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  20. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  21. Guo J, et al. 2022. Nat Biomed Eng. 6:19. PubMed
  22. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  23. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  24. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  25. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  26. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  27. Jin R, et al. 2008. J Immunol. 180:2256. PubMed
  28. Kiuchi M, et al. 2021. J Exp Med. 218:. PubMed
  29. Li X, et al. 2016. MBio. 7: 02232-15. PubMed
  30. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  31. Wen J, et al. 2020. Cell Rep. 31:107566. PubMed
  32. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  33. Fukuishi N, et al. 2014. J Immunol. 193:1886. PubMed
  34. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  35. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  36. Liu YW, et al. 2022. JCI Insight. 7:. PubMed
  37. DiMarco AV, et al. 2022. Cancer Immunol Res. 10:70. PubMed
  38. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  39. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  40. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  41. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  42. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  43. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
RRID
AB_315319 (BioLegend Cat. No. 504105)
AB_315319 (BioLegend Cat. No. 504106)

Antigen Details

Structure
Cytokine; 15-19 kD (Mammalian)
Bioactivity
Differentiation of naïve CD4+ T cells to the TH2 type, proliferation/differentiation of activated B cells, expression of class II MHC antigens, and of low affinity IgE receptors in resting B cells
Cell Sources
Mast cells, T cells, bone marrow stromal cells
Cell Targets
B cells, T cells, monocytes, endothelial cells, fibroblasts
Receptors
Heterodimer IL-4Rα (CD124); γ-subunit (CD132) in common with IL-2R, IL-7R, IL-13R, IL-15R
Cell Type
Tregs
Biology Area
Immunology
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. Boulay J, et al. 1992. Curr. Opin. Immunol. 4:294.
3. Dullens H, et al. 1991. In vivo 5:567.
4. Paul W. 1991. Blood 77:1859.

Regulation
Upregulated by IL-2, platelet activating factor; downregulated by TGF-β
Gene ID
16189 View all products for this Gene ID
UniProt
View information about IL-4 on UniProt.org
Go To Top Version: 3    Revision Date: 07.11.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account